There's a typo in your Oracle headline where it says "debilitating wave of layoffs."
Morning Headlines 8/31/17
AHA Letter To Representative Pat Tiberi
AHA writes a letter to Rep. Pat Tiberi (R-OH), Chairman of the Committee on Ways and Means’ Subcommittee on Health, calling for the cancellation of Meaningful Use Stage 3.
FDA approval brings first gene therapy to the United States
The FDA has approved CAR-T, a gene therapy treatment for certain types of pediatric leukemia, making it the first gene therapy approved for use in the US. Novartis developed the treatment and has put a $475,000 price tag on the drug, far below analyst expectations. In a clinical trial, a single dose of CAR-T left 83 percent of participants cancer free after three months.
Medtronic invests $40 million in robotics company Mazor
Medtronic announces that it has invested $40 million in surgical robot vendor Mazor Robotics, bringing its total investment in the company to $72 million. Medtronic will now become the exclusive distributor of Mazor’s robotic surgery system.
Aetna scoops up rising star from Wal-Mart’s health group to lead Apple Watch partnership
Aetna hires Walmart’s health division director Ben Wanamaker to lead its joint venture with Apple.
Folks should remember that killing MU3 would hurt Medicaid providers much more than hospitals or Medicare EPs. The Medicaid program has a few more years of funding left in it. The other programs – for most hospitals and EPs – do not, and have shifted into the penalty phase.
Time to repeal and never replace meaningfully useless Meaningful Use! GO AHA! GO!